AGENDA – WEDNESDAY, OCTOBER 21st 2020 – NY Endovascular Summit

AGENDA – WEDNESDAY, OCTOBER 21st 2020

LOCATION: etc.venues - Room 1

4:51 pm
Closing Remarks
Prakash Krishnan, MD
4:34 pm
Case 2: Massive Embolization
4:19 pm
Case 1: Iliac Perforation
4:11 pm
Role of Aortic Endograft in Complex Iliac Disease
Rami O. Tadros, MD
SESSION VII: FEM-POP COMPLICATIONS: MY WORST NIGHTMARE
4:03 pm
Choice of Stent for Iliac Artery Stent
George S. Chrysant, MD
3:55 pm
Crossing Iliac Artery CTOs
D. Christopher Metzger, MD
3:23 pm
BREAK / VISIT EXHIBITS
SESSION VI: ILIAC INTERVENTIONS
3:15 pm
Role of Surgery in Fem-Pop Lesions
Christian Bianchi, MD
3:07 pm
DCB in Long Lesions: What Does the Data Show?
Mahmood Razavi, MD
2:59 pm
2:51 pm
DES in Long Lesions and CTO
Ehrin Armstrong, MD
2:43 pm
Covered Stent Long Segment CTO Lesions
Jos C. van den Berg, MD, PhD
2:35 pm
Algorithm for Fem-Pop CTO Crossing: Access, Wires and Devices
D. Christopher Metzger, MD
2:08 pm
Combination Therapy in Calcified Lesions in 2020 (Reality Update)
Brian G. DeRubertis, MD
SESSION V: LESION-BASED DECISION MAKING: CTO AND LONG LESIONS
2:00 pm
Supera is the Stent of Choice in Calcified Lesions
Lawrence A. Garcia, MD
1:52 pm
Lithoplasty in Severe Calcific Lesions
Mahmood Razavi, MD
1:44 pm
Role of Atherectomy in Severe Calcific Lesions: How Do I Choose My Device?
Lawrence A. Garcia, MD
1:36 pm
Image-Guided Therapy in Complex Disease
Bryan T. Fisher, Sr., MD
1:28 pm
DES and DCB in Calcified Lesions: Do They Work?
Ehrin Armstrong, MD
1:20 pm
Classification of Fem-Pop Calcium
Christian Bianchi, MD
12:00 pm
LUNCH / VISIT EXHIBITS
SESSION IV: LESION-BASED DECISION MAKING: FEM POP CALCIUM
11:53 am
Embolization and Thrombus Management in ISR
Brian G. DeRubertis, MD
11:45 am
When Do You Stop and Bypass in Fem-Pop ISR?
Mehdi H. Shishehbor, DO
11:37 am
Rotarex in ISR (European Experience)
Fabrizio Fanelli, MD
11:29 am
Covered Stents in ISR
George Adams, MD
11:21 am
Combination Therapy for ISR: Role of Atherectomy, DCB, DES
Ehrin Armstrong, MD
10:53 am
SIRONA Trial
Dierk Scheinert, MD
SESSION III: LESION-BASED DECISION MAKING: FEM-POP ISR
10:45 am
MagicTouch Study
Sahil A. Parikh, MD
10:37 am
LIMBO-ATX Trial
George Adams, MD
10:29 am
BIOLUX P-III Registry Update
Marianne Brodmann, MD
10:21 am
SOLUTION SFA Trial
Mehdi H. Shishehbor, DO
10:13 am
ILLUMINA PAD Clinical Trial Update
Dierk Scheinert, MD
10:05 am
Contemporary Management of CFA Disease: Is EV Therapy Ready for Prime Time?
Thomas Zeller, MD, PhD
9:45 am
9:30 am
BREAK / VISIT EXHIBITS
SESSION II: FUTURE HORIZONS FOR FEM-POP DISEASE MANAGEMENT
9:21 am
Panel Discussion
9:13 am
Zilver PTX Long-Term Follow-Up and Latest Results
Sahil A. Parikh, MD
9:05 am
Eluvia Long-Term Follow-Up and Latest Results
William A. Gray, MD
8:57 am
Ranger Long-Term Follow-Up and Latest Results
Thomas Zeller, MD, PhD
8:49 am
Stellarex Long-Term Follow-Up and Latest Results
Peter L. Faries, MD
8:41 am
Lutonix Study Long-Term Follow-Up and Latest Results
Marianne Brodmann, MD
8:33 am
IN.PACT SFA Long-Term Follow-Up and Latest Results
Fabrizio Fanelli, MD
8:25 am
Paclitaxel Safety 2020: Where Do We Stand?
William A. Gray, MD
8:05 am
8:00 am
Welcome and Introduction
Prakash Krishnan, MD Samin K. Sharma, MD
SESSION I: UPDATE ON PACLITAXEL COATED THERAPIES
7:30 am
Registration / Continental Breakfast
etc.venues; 360 Madison Avenue – 5th Floor

LOCATION: etc.venues - Room 2

10:40 am
BREAK / VISIT EXHIBITS
10:30 am
Interactive Panel and Case Discussion
9:20 am
Case Presentations
9:10 am
BREAK / VISIT EXHIBITS
9:00 am
Interactive Panel and Case Discussion
8:10 am
Case Presentations
8:00 am
Welcome and Introduction
J. Michael Bacharach, MD
7:30 am
Registration / Continental Breakfast
etc.venues; 360 Madison Avenue – Room 2

LOCATION: etc.venues - Room 2

12:00 pm
Closing Remarks
Karthik Gujja, MD
11:50 am
OMG: Great Save in OBL
Karthik Gujja, MD
11:40 am
Case Presentation
Furqan Tejani, MD
11:30 am
Future of OBL: Bright or Unpredictable?
Karthik Gujja, MD
11:20 am
How to Avoid Complications in OBL
Ali Aboufares, MD
11:10 am
What Patient is Right for You? Case Selection for OBL
Karthik Gujja, MD
11:00 am
OBL vs. Ambulatory Surgical Center: What is Right for You?
David Partridge - Abbott
10:50 am
What Does it Take to Set Up OBL?
Nilesh Balar, MD
SESSION II: OFFICE-BASED ENDOVASCULAR LAB (OBL)

LOCATION: etc.venues - Room 2

5:00 pm
4:45 pm
Panel Discussion
4:30 pm
Complex Case Presentation
Steven Kum, MD
4:15 pm
Differential Diagnosis of Ulcers
Michael J. Trepal, DPM
4:00 pm
Surgical Options for CLI
Christian Bianchi, MD
3:45 pm
Endovascular Approach for CLI
Srini Tummala, MD
3:30 pm
Is there a Role for Surgery in the Claudicant?
Rajiv K. Chander, MD
REVASCULARIZATION FOR CRITICAL LIMB ISCHEMIA
3:15 pm
Endovascular Approach: Role of DCB/Atherectomy and DES
Farhan Majeed, MD
3:05 pm
BREAK / VISIT EXHIBITS
2:50 pm
Plastic Wound Closure Techniques for Challenging Cases
Russell R. Caprioli, DPM
2:35 pm
Wound Care Classifications: What do they Mean?
William D. Spielfogel, DPM
2:20 pm
Offloading Science vs Offloading Nonsense
Jeffrey J. Cusack, DPM
2:05 pm
Have the Rules Changed? Current Consensus in Charcot Foot Management
David Gitlin, DPM
1:50 pm
The Sobering Facts on DLS: What Should Our Goals Be?
Emilio A. Goez, DPM
1:25 pm
Impact of Non-Invasive Testing in PAD and Venous Disease (Physiology/Anatomy)
Daniella Kadian-Dodov, MD
1:10 pm
Vascular Diagnosis for the Podiatrist- Physical exam Tips and Tricks
Ronald M. Guberman, DPM